Ezra Announces New FDA Clearance, Enhancing the Capabilities of Its Full-Body Scan Technology
Ezra, the healthcare AI startup revolutionizing early cancer detection through full-body MRI screening, today announced new 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its ...
BioRestorative Receives FDA Fast Track Designation for BRTX-100 Chronic Lumbar Disc Disease Program
Underscores high unmet need for a therapeutic alternative to opioids and surgical interventions –– Reflects positive preliminary Phase 2 Safety ...
FDA approves first rapid-acting insulin biosimilar for patients with diabetes
Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...